Effect of contrast medium versus low-molecular-weight dextran for intracoronary optical coherence tomography in renal insufficiency.
Contrast Media
/ adverse effects
Coronary Angiography
Coronary Artery Disease
/ diagnostic imaging
Dextrans
Humans
Percutaneous Coronary Intervention
/ adverse effects
Predictive Value of Tests
Renal Insufficiency
Retrospective Studies
Stroke Volume
Tomography, Optical Coherence
Ventricular Function, Left
Contrast media
Coronary artery disease
Dextran
Kidney injury
Optical coherence tomography
Journal
The international journal of cardiovascular imaging
ISSN: 1875-8312
Titre abrégé: Int J Cardiovasc Imaging
Pays: United States
ID NLM: 100969716
Informations de publication
Date de publication:
Sep 2021
Sep 2021
Historique:
received:
01
12
2020
accepted:
12
04
2021
pubmed:
22
4
2021
medline:
16
10
2021
entrez:
21
4
2021
Statut:
ppublish
Résumé
Low-molecular-weight dextran (LMWD) is considered a safe alternative to contrast media to displace blood during optical coherence tomography (OCT) imaging, but concerns remain. The purpose of this study was to investigate whether using LMWD for OCT protects against kidney injury in patients with renal insufficiency compared with contrast media. We retrospectively identified 474 patients with renal insufficiency (estimated glomerular filtration rate < 60 ml/min/1.73 m
Identifiants
pubmed: 33880712
doi: 10.1007/s10554-021-02245-9
pii: 10.1007/s10554-021-02245-9
doi:
Substances chimiques
Contrast Media
0
Dextrans
0
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
2603-2615Informations de copyright
© 2021. The Author(s), under exclusive licence to Springer Nature B.V.
Références
Gruberg L, Mintz GS, Mehran R, Gangas G, Lansky AJ, Kent KM et al (2000) The prognostic implications of further renal function deterioration within 48 h of interventional coronary procedures in patients with pre-existent chronic renal insufficiency. J Am Coll Cardiol 36:1542–1548
doi: 10.1016/S0735-1097(00)00917-7
Rihal CS, Textor SC, Grill DE, Berger PB, Ting HH, Best PJ et al (2002) Incidence and prognostic importance of acute renal failure after percutaneous coronary intervention. Circulation 105:2259–2264
doi: 10.1161/01.CIR.0000016043.87291.33
Mehran R, Dangas GD, Weisbord SD (2019) Contrast-associated acute kidney injury. N Engl J Med 380:2146–2155
doi: 10.1056/NEJMra1805256
Wang F, Peng C, Zhang G, Zhao Q, Xuan C, Wei M et al (2016) Delayed kidney injury following coronary angiography. Exp Ther Med 12:530–534
doi: 10.3892/etm.2016.3315
Prati F, Regar E, Mintz GS, Arbustini E, Di Mario C, Jang IK et al (2010) Expert review document on methodology, terminology, and clinical applications of optical coherence tomography: physical principles, methodology of image acquisition, and clinical application for assessment of coronary arteries and atherosclerosis. Eur Heart J 31:401–415
doi: 10.1093/eurheartj/ehp433
Prati F, Guagliumi G, Mintz GS, Costa M, Regar E, Akasaka T et al (2012) Expert review document part 2: methodology, terminology and clinical applications of optical coherence tomography for the assessment of interventional procedures. Eur Heart J 33:2513–2520
doi: 10.1093/eurheartj/ehs095
Meneveau N, Souteyrand G, Motreff P, Caussin C, Amabile N, Ohlmann P et al (2016) Optical coherence tomography to optimize results of percutaneous coronary intervention in patients with non-ST-elevation acute coronary syndrome: results of the multicenter, randomized DOCTORS study (Does Optical Coherence Tomography Optimize Results of Stenting). Circulation 134:906–917
doi: 10.1161/CIRCULATIONAHA.116.024393
Kubo T, Shinke T, Okamura T, Hibi K, Nakazawa G, Morino Y, et al. Optical frequency domain imaging vs. intravascular ultrasound in percutaneous coronary intervention (OPINION trial): one-year angiographic and clinical results. Eur Heart J. 2017;38:3139–47.
Brezinski M, Saunders K, Jesser C, Li X, Fujimoto J (2001) Index matching to improve optical coherence tomography imaging through blood. Circulation 103:1999–2003
doi: 10.1161/01.CIR.103.15.1999
Ozaki Y, Kitabata H, Tsujioka H, Hosokawa S, Kashiwagi M, Ishibashi K et al (2012) Comparison of contrast media and low-molecular-weight dextran for frequency-domain optical coherence tomography. Circ J 76:922–927
doi: 10.1253/circj.CJ-11-1122
Frick K, Michael TT, Alomar M, Mohammed A, Rangan BV, Abdullah S et al (2014) Low molecular weight dextran provides similar optical coherence tomography coronary imaging compared to radiographic contrast media. Catheter Cardiovasc Interv 84:727–731
doi: 10.1002/ccd.25092
Feest TG (1976) Low molecular weight dextran: a continuing cause of acute renal failure. Br Med J 2:1300
doi: 10.1136/bmj.2.6047.1300
Moran M, Kapsner C (1987) Acute renal failure associated with elevated plasma oncotic pressure. N Engl J Med 317:150–153
doi: 10.1056/NEJM198707163170306
Zwaveling JH, Meulenbelt J, van Xanten NH, Hene RJ (1989) Renal failure associated with the use of dextran-40. Neth J Med 35:321–326
pubmed: 2483959
Dickenmann M, Oettl T, Mihatsch MJ (2008) Osmotic nephrosis: acute kidney injury with accumulation of proximal tubular lysosomes due to administration of exogenous solutes. Am J Kidney Dis 51:491–503
doi: 10.1053/j.ajkd.2007.10.044
Terada N, Kuramochi T, Sugiyama T, Kanaji Y, Hoshino M, Usui E et al (2020) Ventricular fibrillation during optical coherence tomography/optical frequency domain imaging - a large single-center experience. Circ J 84:178–185
doi: 10.1253/circj.CJ-19-0736
Clinical practice guidebook for diagnosis and treatment of chronic kidney disease 2012: Tokyo Igakusha; 2012.
KDIGO (2012) Clinical practice guideline for the evaluation and management of chronic kidney disease. Elsevier, New York
Mehran R, Faggioni M, Chandrasekhar J, Angiolillo DJ, Bertolet B, Jobe RL et al (2018) Effect of a contrast modulation system on contrast media use and the rate of acute kidney injury after coronary angiography. J Am Coll Cardiol Intv 11:1601–1610
doi: 10.1016/j.jcin.2018.04.007
Bleyer AJ, Shemanski LR, Burke GL, Hansen KJ, Appel RG (2000) Tobacco, hypertension, and vascular disease: risk factors for renal functional decline in an older population. Kidney Int 57:2072–2079
doi: 10.1046/j.1523-1755.2000.00056.x
Mehran R, Aymong ED, Nikolsky E, Lasic Z, Iakovou I, Fahy M et al (2004) A simple risk score for prediction of contrast-induced nephropathy after percutaneous coronary intervention: development and initial validation. J Am Coll Cardiol 44:1393–1399
pubmed: 15464318
Balemans CE, Reichert LJ, van Schelven BI, van den Brand JA, Wetzels JF (2012) Epidemiology of contrast material-induced nephropathy in the era of hydration. Radiology 263:706–713
doi: 10.1148/radiol.12111667
Karimi Galougahi K, Zalewski A, Leon MB, Karmpaliotis D, Ali ZA (2016) Optical coherence tomography-guided percutaneous coronary intervention in pre-terminal chronic kidney disease with no radio-contrast administration. Eur Heart J 37:1059
doi: 10.1093/eurheartj/ehv667
Ferraboli R, Malheiro PS, Abdulkader RC, Yu L, Sabbaga E, Burdmann EA (1997) Anuric acute renal failure caused by dextran 40 administration. Ren Fail 19:303–306
doi: 10.3109/08860229709026293
Klotz U, Kroemer H (1987) Clinical pharmacokinetic considerations in the use of plasma expanders. Clin Pharmacokinet 12:123–135
doi: 10.2165/00003088-198712020-00003
Nearman HS, Herman ML (1991) Toxic effects of colloids in the intensive care unit. Crit Care Clin 7:713–723
doi: 10.1016/S0749-0704(18)30302-6